Register for our free email digests:
Crucell Switzerland AG
Division of Johnson & Johnson
www.bernabiotech.com
Latest From Crucell Switzerland AG
Deals Shaping The Medical Industry, September 2014
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced June-August 2014.
CSL's Shortcut from Down Under
Reviewing 2005: The Top Biopharma Stories
Company Information
- Industry
-
Biotechnology
-
Large Molecule
- Antibodies
-
Large Molecule
-
Pharmaceuticals
- Vaccines
- Therapeutic Areas
- Infectious & Viral Diseases
- Alias(es)
- Swiss Serum & Vaccine Institute
- Berna Biotech Ltd.
- Berna Biotech AG
- Ownership
- Private
- Headquarters
-
Worldwide
-
Europe
-
Western Europe
-
Switzerland
-
Switzerland
-
Western Europe
-
Europe
- Parent & Subsidiaries
- Johnson & Johnson
- Senior Management
-
Kuno Sommer, CEO
Rolf Gasser, CFO - Contact Info
-
Crucell Switzerland AG
Phone: (41) 31 980 6111
Rehhagstrasse 79
Berne, CH-30181
Switzerland
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice